Treatment of Autoimmune Inflammation by a TLR7 Ligand Regulating the Innate Immune System

• Tomoko Hayashi,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Shiyin Yao,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Brian Crain,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Michael Chan,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Rommel I. Tawatao,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Christine Gray,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Linda Vuong,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Fitzgerald Lao,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Howard B. Cottam,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Dennis A. Carson,

  Affiliation Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Maripat Corr

  * E-mail: mcorr@ucsd.edu

  Affiliation Department of Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯